We read with great interest Law et al.'s retrospective analysis of trends in the rates of awake fibreoptic intubation (FOI). 1 We offer our own data that further confirm that the widespread use of video laryngoscopy (VL) -at even higher rates than reported by Law -does not impact the overall incidence of awake FOI. We have recently converted our anesthetic department (comprising 14 theatres) to one where the default intubation modality is VL. Although we already had access to the Storz C-MACÒ VL in our theatre suites in 2012, the availability was limited, and VL was used purely as a rescue tool. By 2013, however, we transitioned to VL as the first-choice laryngoscopic modality, and throughout 2014, VL has been universally available and used in approximately 80% of in-theatre intubations. We plan to increase this to 100% in the near future.
To the Editor,
We read with great interest Law et al.'s retrospective analysis of trends in the rates of awake fibreoptic intubation (FOI) . 1 We offer our own data that further confirm that the widespread use of video laryngoscopy (VL) -at even higher rates than reported by Law -does not impact the overall incidence of awake FOI. We have recently converted our anesthetic department (comprising 14 theatres) to one where the default intubation modality is VL. Although we already had access to the Storz C-MACÒ VL in our theatre suites in 2012, the availability was limited, and VL was used purely as a rescue tool. By 2013, however, we transitioned to VL as the first-choice laryngoscopic modality, and throughout 2014, VL has been universally available and used in approximately 80% of in-theatre intubations. We plan to increase this to 100% in the near future.
Although we perform a smaller total number of intubations than QEII hospital (Table) and perform intubations in only a third of our general anesthetics, our rate of FOI per intubation is quite similar to that reported by Law and has not increased since our change to routine use of VL.
Law et al. concluded that, despite increased availability and use of VL, the rates of awake FOI had not significantly changed in their institution. Of importance, this is with a reported VL usage of only 8-10%. In a different healthcare environment, we also discerned no change in the rates of awake FOI despite introducing universal availability and routine use of VL.
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